Can a shot of interferon gamma help ventilated patients beat pneumonia faster?

NCT ID NCT05843786

First seen Jun 27, 2026 · Last updated Jul 07, 2026 · Updated 2 times

Summary

This study tests whether a drug called interferon gamma can help intensive care patients recover more quickly from pneumonia they got while on a breathing machine. The drug aims to boost the immune system, which is often weakened after severe illness or injury. About 132 adults will receive either the drug or a placebo, and researchers will measure how many days they need the ventilator.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PNEUMONIA, VENTILATOR-ASSOCIATED are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Critical Illness injury Pneumonia, Ventilator-Associated Sepsis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • CHU Limoges

    NOT_YET_RECRUITING

    Limoges, France

  • Département Anesthésie-Réanimation

    NOT_YET_RECRUITING

    Saint-Etienne, 42055, France

  • Hôpital Edouard Herriot - Médecine intensive - réanimation

    NOT_YET_RECRUITING

    Lyon, France

  • Médecine intensive- Réanimation

    RECRUITING

    Paris, 75014, France

  • Service civilo-militaire d'Anesthésie-Réanimation et Médecine Périopératoire

    RECRUITING

    Lyon, 69003, France

  • Service d'Anesthésie-réanimation-médecine intensive Hôpital Lyon Sud

    RECRUITING

    Pierre-Bénite, 69395, France

  • Service d'anesthésie-réanimation, unité de réanimation chirurgicale Picard

    NOT_YET_RECRUITING

    Nancy, 54511, France

  • Service de reanimation chirurgicale Hopital Croix-Rousse

    NOT_YET_RECRUITING

    Lyon, 69004, France

  • Service de reanimation médicale hôpital de la Croix-Rousse

    RECRUITING

    Lyon, 69004, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.